{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:53:57Z","timestamp":1763754837042,"version":"3.45.0"},"reference-count":33,"publisher":"Oncology Nursing Society (ONS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.1188\/22.cjon.261-267","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:39:29Z","timestamp":1653305969000},"page":"261-267","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of Opioid Misuse Risk in Patients With Cancer"],"prefix":"10.1188","volume":"26","author":[{"given":"Michelle","family":"Dannenberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Broglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Bahorik, A.L., Satre, D.D., Kline-Simon, A.H., Weisner, C.M., & Campbell, C.I. (2017). Alcohol, cannabis, and opioid use disorders, and disease burden in an integrated health care system. Journal of Addiction Medicine, 11(1), 3\u20139. https:\/\/doi.org\/10.1097\/ADM.0000000000000260","DOI":"10.1097\/ADM.0000000000000260"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Barclay, J.S., Owens, J.E., & Blackhall, L.J. (2014). Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen. Supportive Care in Cancer, 22(7), 1883\u20131888. https:\/\/doi.org\/10.1007\/s00520-014-2167-6","DOI":"10.1007\/s00520-014-2167-6"},{"key":"3","unstructured":"Broglio, K., Dimilia, P., Savage, S., & Bruce, M.L. (2019, March 20\u201322). Screening for substance use disorder and alcohol use disorder in oncology [Conference session]. National Institute of Drug Abuse, Clinical Trials Network Annual Steering Committee Meeting, Washington, DC."},{"key":"4","doi-asserted-by":"crossref","unstructured":"Carmichael, A., Morgan, L., & Del Fabbro, E. (2016). Identifying and assessing the risk of opioid abuse in patients with cancer: An integrative review. Substance Abuse and Rehabilitation, 7, 71\u201379. https:\/\/doi.org\/10.2147\/SAR.S85409","DOI":"10.2147\/SAR.S85409"},{"key":"5","unstructured":"Centers for Disease Control and Prevention. (2020). Alcohol and public health: Alcohol-related disease impact (ARDI). https:\/\/nccd.cdc.gov\/DPH_ARDI\/default\/default.aspx"},{"key":"6","unstructured":"Centers for Disease Control and Prevention. (2021). Drug overdose. https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html#three-waves"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Cheatle, M.D., Compton, P.A., Dhingra, L., Wasser, T.E., & O\u2019Brien, C.P. (2019). Development of the revised Opioid Risk Tool to predict opioid use disorder in patients with chronic nonmalignant pain. Journal of Pain, 20(7), 842\u2013851. https:\/\/doi.org\/10.1016\/j.jpain.2019.01.011","DOI":"10.1016\/j.jpain.2019.01.011"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Childers, J.W., King, L.A., & Arnold, R.M. (2015). Chronic pain and risk factors for opioid misuse in a palliative care clinic. American Journal of Hospice and Palliative Medicine, 32(6), 654\u2013659. https:\/\/doi.org\/10.1177\/1049909114531445","DOI":"10.1177\/1049909114531445"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Choflet, A., Narang, A.K., Hoofring. L.H., Bonerigo, S., Mian, O.Y., Katulis, L., . . . Appling, S. (2016). Prevalence of substance use in patients with cancer receiving radiation therapy. Clinical Journal of Oncology Nursing, 20(4), 397\u2013402. https:\/\/doi.org\/10.1188\/16.CJON.397-402.","DOI":"10.1188\/16.CJON.397-402"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Dowell, D., Haegerich, T.M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA, 315(15), 1624\u20131645. https:\/\/doi.org\/10.1001\/jama.2016.1464","DOI":"10.1001\/jama.2016.1464"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Fredheim, O.M., Skurtveit, S., Handal, M., & Hjellvik, V. (2019). A complete national cohort study of prescriptions of analgesics and benzodiazepines to cancer survivors in Norway 10 years after diagnosis. Pain, 160(4), 852\u2013859. https:\/\/doi.org\/10.1097\/j.pain.0000000000001459","DOI":"10.1097\/j.pain.0000000000001459"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Garcia, C., Lefkowits, C., Pelkofski, E., Blackhall, L., & Duska, L.R. (2017). Prospective screening with the validated Opioid Risk Tool demonstrates gynecologic oncology patients are at low risk for opioid misuse. Gynecologic Oncology, 147(2), 456\u2013459.","DOI":"10.1016\/j.ygyno.2017.08.008"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Glare, P.A., Davies, P.S., Finlay, E., Gulati, A., Lemanne, D., Moryl, N., . . . Syrjala, K.L. (2014). Pain in cancer survivors. Journal of Clinical Oncology, 32(16), 1739\u20131747. https:\/\/doi.org\/10.1200\/JCO.2013.52.4629","DOI":"10.1200\/JCO.2013.52.4629"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Greiner, R.S., Boselli, D., Patel, J.N., Salib, M., Edelen, C., & Walsh, D. (2020). Opioid risk screening in an oncology palliative medicine clinic. JCO Oncology Practice, 16(11), e1332\u2013e1342.","DOI":"10.1200\/OP.20.00043"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Ho, P., & Rosenheck, R. (2018). Substance use disorder among current cancer patients: Rates and correlates nationally in the Department of Veterans Affairs. Psychosomatics, 59(3), 267\u2013276. https:\/\/doi.org\/10.1016\/j.psym.2018.01.003","DOI":"10.1016\/j.psym.2018.01.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Jairam, V., Yang, D.X., Pasha, S., Soulos, P., Gross, C.P., Yu, J.B., & Park, H.S. (2020). Temporal trends in opioid prescribing patterns among oncologists in the Medicare population. Journal of the National Cancer Institute, 113(3), 274\u2013281. https:\/\/doi.org\/10.1093\/jnci\/djaa110","DOI":"10.1093\/jnci\/djaa110"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Koyyalagunta, D., Bruera, E., Aigner, C., Nusrat, H., Driver, L., & Novy, D. (2013). Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. Pain Medicine, 14(5), 667\u2013675. https:\/\/doi.org\/10.1111\/pme.12100","DOI":"10.1111\/pme.12100"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Krashin, D., Murinova, N., Jumelle, P., & Ballantyne, J. (2015). Opioid risk assessment in palliative medicine. Expert Opinion on Drug Safety, 14(7), 1023\u20131033. https:\/\/doi.org\/10.1517\/14740338.2015.1041915","DOI":"10.1517\/14740338.2015.1041915"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Kwekkeboom, K., Serlin, R.C., Ward, S.E., LeBlanc, T.W., Ogunseitan, A., & Cleary, J. (2020). Revisiting patient-related barriers to cancer pain management in the context of the US opioid crisis. Pain, 162(6), 1840\u20131847. https:\/\/doi.org\/10.1097\/j.pain.0000000000002173","DOI":"10.1097\/j.pain.0000000000002173"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Liebling, D., Mehta, N., & Gulati, A. (2019). Opioid screening practices in the cancer pain patient. Journal of Palliative Medicine, 22(1), 10\u201317. https:\/\/doi.org\/10.1089\/jpm.2018.0168","DOI":"10.1089\/jpm.2018.0168"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Luckett, T., Newton-John, T., Phillips, J., Holliday, S., Giannitrapani, K., Powell-Davies, G., . . . Lorenz, K. (2020). Risk of opioid misuse in people with cancer and pain and related clinical considerations: A qualitative study of the perspectives of Australian general practitioners. BMJ Open, 10(2), 1\u201311. https:\/\/doi.org\/10.1136\/bmjopen-2019-034363","DOI":"10.1136\/bmjopen-2019-034363"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Ma, J.D., Horton, J.M., Hwang, M., Atayee, R.S., & Roeland, E.J. (2014). A single-center, retrospective analysis evaluating the utilization of the Opioid Risk Tool in opioid-treated cancer patients. Journal of Pain and Palliative Care Pharmacotherapy, 28(1), 4\u20139. https:\/\/doi.org\/10.3109\/15360288.2013.869647","DOI":"10.3109\/15360288.2013.869647"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Manchikanti, L., Manchikanti, K.N., Kaye, A.D., Kaye, A.M., & Hirsch, J.A. (2018). Challenges and concerns of persistent opioid use in cancer patients. Expert Review of Anticancer Therapy, 18(7), 705\u2013718. https:\/\/doi.org\/10.1080\/14737140.2018.1474103","DOI":"10.1080\/14737140.2018.1474103"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Mitchell, J.L., Blackhall, L.J., & Barclay, J.S. (2019) Screening for opioid misuse in the nonhospitalized seriously ill patient. Journal of Palliative Medicine, 22(9), 1115\u20131119. https:\/\/doi.org\/10.1089\/jpm.2018.0638","DOI":"10.1089\/jpm.2018.0638"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Ownby, K.K. (2019). Use of the distress thermometer in clinical practice. Journal of the Advanced Practitioner in Oncology, 10(2), 175\u2013179.","DOI":"10.6004\/jadpro.2019.10.2.7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Paice, J.A. (2019). Pain in cancer survivors: How to manage. Current Treatment Options in Oncology, 20(6), 48. https:\/\/doi.org\/10.1007\/s11864-019-0647-0","DOI":"10.1007\/s11864-019-0647-0"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Posternak, V., Dunn, L.B., Dhruva, A., Paul, S.M., Luce, J., Mastick, J., . . . Miaskowski, C. (2016). Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain. Pain, 157(4), 892\u2013900.","DOI":"10.1097\/j.pain.0000000000000456"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Rauenzahn, S., Sima, A., Cassel, B., Noreika, D., Gomez, T.H., Ryan, L., . . . Del Fabbro, E. (2017). Urine drug screen findings among ambulatory oncology patients in a supportive care clinic. Supportive Care in Cancer, 25(6), 1859\u20131864.","DOI":"10.1007\/s00520-017-3575-1"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Sutradhar, R., Lokku, A., & Barbera, L. (2017). Cancer survivorship and opioid prescribing rates: A population-based matched cohort study among individuals with and without a history of cancer. Cancer, 123(21), 4286\u20134293. https:\/\/doi.org\/10.1002\/cncr.30839","DOI":"10.1002\/cncr.30839"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Swarm, R.A., Paice, J.A., Anghelescu, D.L., Are, M., Bruce, J.Y., Buga, S., . . . Gurski, L.A. (2019). NCCN Guidelines for adult cancer pain. Journal of the National Comprehensive Cancer Network, 17(8), 977\u20131007. https:\/\/doi.org\/10.6004\/jnccn.2019.0038","DOI":"10.6004\/jnccn.2019.0038"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Teulings, L., & Broglio, K. (2020). Opioid misuse risk: Implementing screening protocols in an ambulatory oncology clinic. Clinical Journal of Oncology Nursing, 24(1), 11\u201314. https:\/\/doi.org\/10.1188\/20.CJON.11-14","DOI":"10.1188\/20.CJON.11-14"},{"key":"32","doi-asserted-by":"crossref","unstructured":"van den Beuken-van Everdingen, M.H.J., Hochstenbach, L.M.J., Joosten, E.A.J., Tjan-Heijnen, V.C.G., & Janssen, D.J.A. (2016). Update on prevalence of pain in patients with cancer: Systematic review and meta-analysis. Journal of Pain and Symptom Management, 51(6), 1070\u20131090.e9. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.340","DOI":"10.1016\/j.jpainsymman.2015.12.340"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Webster, L.R., & Webster, R.M. (2005). Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Medicine, 6(6), 432\u2013442.","DOI":"10.1111\/j.1526-4637.2005.00072.x"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/26\/3\/prevalence-opioid-misuse-risk-patients-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:48:55Z","timestamp":1763754535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/26\/3\/prevalence-opioid-misuse-risk-patients-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1188\/22.cjon.261-267","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}